FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223485211> ?p ?o ?g. }

• W4223485211 endingPage "101922" @default.
• W4223485211 startingPage "101922" @default.
• W4223485211 abstract "The liver regulates lipid metabolism. Decreasing mTOR (mechanistic target of rapamycin complex 1) and enhancing AMPK (AMP-activated protein kinase) help degrade hepatic diet-induced accumulated lipids. Therefore, the glucagon-like peptide type 1 receptor agonist (GLP-1) is indicated to treat obesity-related liver metabolic alterations. Then, we investigated the effects of semaglutide (recent GLP-1) by analyzing the liver mTORC1/AMPK pathway genes in obese mice.C57BL/6 male mice were separated into two groups and submitted for 16 weeks of obesity induction. Then they were treated for an additional four weeks with semaglutide (subcutaneous, 40 μg/kg once every three days). The groups formed were: C, control group; CS, control group plus semaglutide; HF, high-fat group; HFS, high-fat group plus semaglutide. Next, the livers were dissected, and rapidly fragments of all lobes were kept and frozen at -80° C for analysis (RT-qPCR).Liver markers for the mTOR pathway associated with anabolism and lipogenesis de novo were increased in the HF group compared to the C group but comparatively attenuated by semaglutide. Also, liver markers for the AMPK pathway, which regulates chemical pathways involving the cell's primary energy source, were impaired in the HF group than in the C group but partly restored by semaglutide.the mTOR pathway was attenuated, and the insulin signaling and the AMPK pathway were enhanced by semaglutide, ameliorating the liver gene expressions related to the metabolism of obese mice. These findings are promising in delaying the progression of nonalcoholic fatty liver disease." @default.
• W4223485211 created "2022-04-15" @default.
• W4223485211 creator A5002457194 @default.
• W4223485211 creator A5024493537 @default.
• W4223485211 creator A5042697708 @default.
• W4223485211 creator A5072346695 @default.
• W4223485211 creator A5084203631 @default.
• W4223485211 date "2022-06-01" @default.
• W4223485211 modified "2023-10-18" @default.
• W4223485211 title "The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice" @default.
• W4223485211 cites W1831301545 @default.
• W4223485211 cites W1994142435 @default.
• W4223485211 cites W1998265194 @default.
• W4223485211 cites W2021943078 @default.
• W4223485211 cites W2030845800 @default.
• W4223485211 cites W2059553551 @default.
• W4223485211 cites W2091330563 @default.
• W4223485211 cites W2530564279 @default.
• W4223485211 cites W2572741715 @default.
• W4223485211 cites W2651766544 @default.
• W4223485211 cites W2773698516 @default.
• W4223485211 cites W2897199552 @default.
• W4223485211 cites W2901979245 @default.
• W4223485211 cites W2913917435 @default.
• W4223485211 cites W2913950552 @default.
• W4223485211 cites W2923302310 @default.
• W4223485211 cites W2954905478 @default.
• W4223485211 cites W2997593080 @default.
• W4223485211 cites W2998742236 @default.
• W4223485211 cites W3006720658 @default.
• W4223485211 cites W3029188122 @default.
• W4223485211 cites W3047111872 @default.
• W4223485211 cites W3047856402 @default.
• W4223485211 cites W3047879827 @default.
• W4223485211 cites W3082461370 @default.
• W4223485211 cites W3102426258 @default.
• W4223485211 cites W3106715659 @default.
• W4223485211 cites W3120409850 @default.
• W4223485211 cites W3127371223 @default.
• W4223485211 cites W3129305070 @default.
• W4223485211 cites W3138431202 @default.
• W4223485211 cites W3175962993 @default.
• W4223485211 cites W3180993292 @default.
• W4223485211 cites W3183204157 @default.
• W4223485211 cites W3198173302 @default.
• W4223485211 cites W3213076618 @default.
• W4223485211 cites W3215996763 @default.
• W4223485211 cites W4200049992 @default.
• W4223485211 doi "https://doi.org/10.1016/j.clinre.2022.101922" @default.
• W4223485211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35427802" @default.
• W4223485211 hasPublicationYear "2022" @default.
• W4223485211 type Work @default.
• W4223485211 citedByCount "7" @default.
• W4223485211 countsByYear W42234852112022 @default.
• W4223485211 countsByYear W42234852112023 @default.
• W4223485211 crossrefType "journal-article" @default.
• W4223485211 hasAuthorship W4223485211A5002457194 @default.
• W4223485211 hasAuthorship W4223485211A5024493537 @default.
• W4223485211 hasAuthorship W4223485211A5042697708 @default.
• W4223485211 hasAuthorship W4223485211A5072346695 @default.
• W4223485211 hasAuthorship W4223485211A5084203631 @default.
• W4223485211 hasConcept C126322002 @default.
• W4223485211 hasConcept C134018914 @default.
• W4223485211 hasConcept C141359234 @default.
• W4223485211 hasConcept C170493617 @default.
• W4223485211 hasConcept C184235292 @default.
• W4223485211 hasConcept C185280430 @default.
• W4223485211 hasConcept C2777180221 @default.
• W4223485211 hasConcept C2778938600 @default.
• W4223485211 hasConcept C2780124434 @default.
• W4223485211 hasConcept C2781308992 @default.
• W4223485211 hasConcept C2909862629 @default.
• W4223485211 hasConcept C4733338 @default.
• W4223485211 hasConcept C55493867 @default.
• W4223485211 hasConcept C555293320 @default.
• W4223485211 hasConcept C62478195 @default.
• W4223485211 hasConcept C71924100 @default.
• W4223485211 hasConcept C86554907 @default.
• W4223485211 hasConcept C86803240 @default.
• W4223485211 hasConcept C97029542 @default.
• W4223485211 hasConcept C98490376 @default.
• W4223485211 hasConceptScore W4223485211C126322002 @default.
• W4223485211 hasConceptScore W4223485211C134018914 @default.
• W4223485211 hasConceptScore W4223485211C141359234 @default.
• W4223485211 hasConceptScore W4223485211C170493617 @default.
• W4223485211 hasConceptScore W4223485211C184235292 @default.
• W4223485211 hasConceptScore W4223485211C185280430 @default.
• W4223485211 hasConceptScore W4223485211C2777180221 @default.
• W4223485211 hasConceptScore W4223485211C2778938600 @default.
• W4223485211 hasConceptScore W4223485211C2780124434 @default.
• W4223485211 hasConceptScore W4223485211C2781308992 @default.
• W4223485211 hasConceptScore W4223485211C2909862629 @default.
• W4223485211 hasConceptScore W4223485211C4733338 @default.
• W4223485211 hasConceptScore W4223485211C55493867 @default.
• W4223485211 hasConceptScore W4223485211C555293320 @default.
• W4223485211 hasConceptScore W4223485211C62478195 @default.
• W4223485211 hasConceptScore W4223485211C71924100 @default.
• W4223485211 hasConceptScore W4223485211C86554907 @default.

• next